These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14691613)

  • 1. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs.
    Garin E; Noiret N; Malbert C; Lepareur N; Roucoux A; Caulet-Maugendre S; Moisan A; Lecloirec J; Herry JY; Bourguet P
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma.
    Garin E; Denizot B; Noiret N; Lepareur N; Roux J; Moreau M; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
    Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig.
    Garin E; Noiret N; Malbert CH; Lepareur N; Roucoux A; Dazord L; Caulet-Maugendre S; Turlin B; Moisan A; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
    Nucl Med Commun; 2004 Mar; 25(3):291-7. PubMed ID: 15094449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
    Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ
    Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
    Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M
    Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with
    Delaunay K; Edeline J; Rolland Y; Lepareur N; Laffont S; Palard X; Bouvry C; Le Sourd S; Pracht M; Ardisson V; Noiret N; Bellissant É; Garin E
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1506-1517. PubMed ID: 30715571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma.
    Garin E; Rakotonirina H; Lejeune F; Denizot B; Roux J; Noiret N; Mesbah H; Herry JY; Bourguet P; Lejeune JJ
    Nucl Med Commun; 2006 Apr; 27(4):363-9. PubMed ID: 16531923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
    Lambert B; Bacher K; Defreyne L; Van Vlierberghe H; Jeong JM; Wang RF; van Meerbeeck J; Smeets P; Troisi R; Thierens H; De Vos F; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.
    Lambert B; Bacher K; Defreyne L; Gemmel F; Van Vlierberghe H; Jeong JM; Dierckx RA; Van de Wiele C; Thierens H; De Vos F
    J Nucl Med; 2005 Jan; 46(1):60-6. PubMed ID: 15632035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
    Lee YS; Jeong JM; Kim YJ; Chang YS; Lee HJ; Son M; Lee JW; Yoon HS; Kang WJ; Lee DS; Chung JK; Lee MC; Suh YG
    Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer.
    Jeong JM; Kim YJ; Lee YS; Ko JI; Son M; Lee DS; Chung JK; Park JH; Lee MC
    Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution.
    Ballot S; Noiret N; Hindré F; Denizot B; Garin E; Rajerison H; Benoit JP
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):602-7. PubMed ID: 16450136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy.
    Wang SJ; Lin WY; Chen MN; Hsieh BT; Shen LH; Tsai ZT; Ting G; Knapp FF
    Appl Radiat Isot; 1996 Mar; 47(3):267-71. PubMed ID: 8935963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
    Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
    Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
    Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
    J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 188 Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer.
    Lee YS; Jeong JM; Kim YJ; Chung JW; Park JH; Suh YG; Lee DS; Chung JK; Lee MC
    Nucl Med Commun; 2002 Mar; 23(3):237-42. PubMed ID: 11891481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
    Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
    Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of lipiodol following hepatic arterial injection.
    Hind RE; Loizidou M; Fleming J; Batty V; Birch S; Taylor I
    Eur J Surg Oncol; 1992 Apr; 18(2):162-7. PubMed ID: 1316290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases.
    Liepe K; Kotzerke J; Lambert B
    J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601
    [No Abstract]   [Full Text] [Related]  

  • 20. Automation of labelling of Lipiodol with high-activity generator-produced 188Re.
    Lepareur N; Ardisson V; Noiret N; Boucher E; Raoul JL; Clément B; Garin E
    Appl Radiat Isot; 2011 Feb; 69(2):426-30. PubMed ID: 21106381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.